
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease
Panu K. Luukkonen, You Zhou, Sanja Sädevirta, et al.
Journal of Hepatology (2016) Vol. 64, Iss. 5, pp. 1167-1175
Open Access | Times Cited: 401
Panu K. Luukkonen, You Zhou, Sanja Sädevirta, et al.
Journal of Hepatology (2016) Vol. 64, Iss. 5, pp. 1167-1175
Open Access | Times Cited: 401
Showing 1-25 of 401 citing articles:
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman, Brent A. Neuschwander‐Tetri, Mary E. Rinella, et al.
Nature Medicine (2018) Vol. 24, Iss. 7, pp. 908-922
Open Access | Times Cited: 3331
Scott L. Friedman, Brent A. Neuschwander‐Tetri, Mary E. Rinella, et al.
Nature Medicine (2018) Vol. 24, Iss. 7, pp. 908-922
Open Access | Times Cited: 3331
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease
Mohammed Eslam, Arun J. Sanyal, Jacob George, et al.
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1999-2014.e1
Open Access | Times Cited: 2615
Mohammed Eslam, Arun J. Sanyal, Jacob George, et al.
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1999-2014.e1
Open Access | Times Cited: 2615
Mechanisms of Insulin Action and Insulin Resistance
Max C. Petersen, Gerald I. Shulman
Physiological Reviews (2018) Vol. 98, Iss. 4, pp. 2133-2223
Open Access | Times Cited: 2211
Max C. Petersen, Gerald I. Shulman
Physiological Reviews (2018) Vol. 98, Iss. 4, pp. 2133-2223
Open Access | Times Cited: 2211
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Rohit Loomba, Scott L. Friedman, Gerald I. Shulman
Cell (2021) Vol. 184, Iss. 10, pp. 2537-2564
Open Access | Times Cited: 1272
Rohit Loomba, Scott L. Friedman, Gerald I. Shulman
Cell (2021) Vol. 184, Iss. 10, pp. 2537-2564
Open Access | Times Cited: 1272
Regulation of hepatic glucose metabolism in health and disease
Max C. Petersen, Daniel F. Vatner, Gerald I. Shulman
Nature Reviews Endocrinology (2017) Vol. 13, Iss. 10, pp. 572-587
Open Access | Times Cited: 920
Max C. Petersen, Daniel F. Vatner, Gerald I. Shulman
Nature Reviews Endocrinology (2017) Vol. 13, Iss. 10, pp. 572-587
Open Access | Times Cited: 920
The integrative biology of type 2 diabetes
Michael Roden, Gerald I. Shulman
Nature (2019) Vol. 576, Iss. 7785, pp. 51-60
Open Access | Times Cited: 909
Michael Roden, Gerald I. Shulman
Nature (2019) Vol. 576, Iss. 7785, pp. 51-60
Open Access | Times Cited: 909
Metabolomics and Metabolic Diseases: Where Do We Stand?
Christopher B. Newgard
Cell Metabolism (2016) Vol. 25, Iss. 1, pp. 43-56
Open Access | Times Cited: 628
Christopher B. Newgard
Cell Metabolism (2016) Vol. 25, Iss. 1, pp. 43-56
Open Access | Times Cited: 628
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
Amedeo Lonardo, Fabio Nascimbeni, Alessandro Mantovani, et al.
Journal of Hepatology (2017) Vol. 68, Iss. 2, pp. 335-352
Closed Access | Times Cited: 626
Amedeo Lonardo, Fabio Nascimbeni, Alessandro Mantovani, et al.
Journal of Hepatology (2017) Vol. 68, Iss. 2, pp. 335-352
Closed Access | Times Cited: 626
Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases
Varman T. Samuel, Gerald I. Shulman
Cell Metabolism (2017) Vol. 27, Iss. 1, pp. 22-41
Open Access | Times Cited: 609
Varman T. Samuel, Gerald I. Shulman
Cell Metabolism (2017) Vol. 27, Iss. 1, pp. 22-41
Open Access | Times Cited: 609
The complex link between NAFLD and type 2 diabetes mellitus — mechanisms and treatments
Giovanni Targher, Kathleen E. Corey, Christopher D. Byrne, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 9, pp. 599-612
Closed Access | Times Cited: 586
Giovanni Targher, Kathleen E. Corey, Christopher D. Byrne, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 9, pp. 599-612
Closed Access | Times Cited: 586
Insulin Resistance: From Mechanisms to Therapeutic Strategies
Shin-Hae Lee, Shi‐Young Park, Cheol Soo Choi
Diabetes & Metabolism Journal (2021) Vol. 46, Iss. 1, pp. 15-37
Open Access | Times Cited: 528
Shin-Hae Lee, Shi‐Young Park, Cheol Soo Choi
Diabetes & Metabolism Journal (2021) Vol. 46, Iss. 1, pp. 15-37
Open Access | Times Cited: 528
Why does obesity cause diabetes?
Samuel Klein, Amalia Gastaldelli, Hannele Yki‐Järvinen, et al.
Cell Metabolism (2022) Vol. 34, Iss. 1, pp. 11-20
Open Access | Times Cited: 490
Samuel Klein, Amalia Gastaldelli, Hannele Yki‐Järvinen, et al.
Cell Metabolism (2022) Vol. 34, Iss. 1, pp. 11-20
Open Access | Times Cited: 490
The aetiology and molecular landscape of insulin resistance
David E. James, Jacqueline Stöckli, Morris J. Birnbaum
Nature Reviews Molecular Cell Biology (2021) Vol. 22, Iss. 11, pp. 751-771
Closed Access | Times Cited: 437
David E. James, Jacqueline Stöckli, Morris J. Birnbaum
Nature Reviews Molecular Cell Biology (2021) Vol. 22, Iss. 11, pp. 751-771
Closed Access | Times Cited: 437
Sphingolipids and phospholipids in insulin resistance and related metabolic disorders
Peter J. Meikle, Scott A. Summers
Nature Reviews Endocrinology (2016) Vol. 13, Iss. 2, pp. 79-91
Closed Access | Times Cited: 370
Peter J. Meikle, Scott A. Summers
Nature Reviews Endocrinology (2016) Vol. 13, Iss. 2, pp. 79-91
Closed Access | Times Cited: 370
Targeting a ceramide double bond improves insulin resistance and hepatic steatosis
Bhagirath Chaurasia, Trevor S. Tippetts, Rafael Mayoral, et al.
Science (2019) Vol. 365, Iss. 6451, pp. 386-392
Open Access | Times Cited: 360
Bhagirath Chaurasia, Trevor S. Tippetts, Rafael Mayoral, et al.
Science (2019) Vol. 365, Iss. 6451, pp. 386-392
Open Access | Times Cited: 360
Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals
Alessandro Mantovani, Graziana Petracca, Giorgia Beatrice, et al.
Gut (2020) Vol. 70, Iss. 5, pp. 962-969
Open Access | Times Cited: 360
Alessandro Mantovani, Graziana Petracca, Giorgia Beatrice, et al.
Gut (2020) Vol. 70, Iss. 5, pp. 962-969
Open Access | Times Cited: 360
Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars
Panu K. Luukkonen, Sanja Sädevirta, You Zhou, et al.
Diabetes Care (2018) Vol. 41, Iss. 8, pp. 1732-1739
Open Access | Times Cited: 358
Panu K. Luukkonen, Sanja Sädevirta, You Zhou, et al.
Diabetes Care (2018) Vol. 41, Iss. 8, pp. 1732-1739
Open Access | Times Cited: 358
Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action
Fernando Bril, Kenneth Cusi
Diabetes Care (2017) Vol. 40, Iss. 3, pp. 419-430
Open Access | Times Cited: 316
Fernando Bril, Kenneth Cusi
Diabetes Care (2017) Vol. 40, Iss. 3, pp. 419-430
Open Access | Times Cited: 316
Roles of Diacylglycerols and Ceramides in Hepatic Insulin Resistance
Max C. Petersen, Gerald I. Shulman
Trends in Pharmacological Sciences (2017) Vol. 38, Iss. 7, pp. 649-665
Open Access | Times Cited: 315
Max C. Petersen, Gerald I. Shulman
Trends in Pharmacological Sciences (2017) Vol. 38, Iss. 7, pp. 649-665
Open Access | Times Cited: 315
Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests
Mojgan Masoodi, Amalia Gastaldelli, Tuulia Hyötyläinen, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 12, pp. 835-856
Closed Access | Times Cited: 314
Mojgan Masoodi, Amalia Gastaldelli, Tuulia Hyötyläinen, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 12, pp. 835-856
Closed Access | Times Cited: 314
Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity
Herbert Tilg, Timon E. Adolph, Michael Dudek, et al.
Nature Metabolism (2021) Vol. 3, Iss. 12, pp. 1596-1607
Closed Access | Times Cited: 303
Herbert Tilg, Timon E. Adolph, Michael Dudek, et al.
Nature Metabolism (2021) Vol. 3, Iss. 12, pp. 1596-1607
Closed Access | Times Cited: 303
Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication
Jan‐Bernd Funcke, Philipp E. Scherer
Journal of Lipid Research (2019) Vol. 60, Iss. 10, pp. 1648-1697
Open Access | Times Cited: 259
Jan‐Bernd Funcke, Philipp E. Scherer
Journal of Lipid Research (2019) Vol. 60, Iss. 10, pp. 1648-1697
Open Access | Times Cited: 259
Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease
Vian Azzu, Michèle Vacca, Sam Virtue, et al.
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1899-1912
Open Access | Times Cited: 255
Vian Azzu, Michèle Vacca, Sam Virtue, et al.
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1899-1912
Open Access | Times Cited: 255
The Impact of Aging on Adipose Function and Adipokine Synthesis
Peter Mancuso, Benjamin Bouchard
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 246
Peter Mancuso, Benjamin Bouchard
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 246
Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis
Maria Apostolopoulou, Ruth Gordillo, Chrysi Koliaki, et al.
Diabetes Care (2018) Vol. 41, Iss. 6, pp. 1235-1243
Open Access | Times Cited: 245
Maria Apostolopoulou, Ruth Gordillo, Chrysi Koliaki, et al.
Diabetes Care (2018) Vol. 41, Iss. 6, pp. 1235-1243
Open Access | Times Cited: 245